Clinical Trial Update: Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completion of a study evaluating Neulasta (pegfilgrastim) in subjects with advanced non-small cell lung cancer during chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Non-Small Cell Lung Cancer | Phase 4 | Status: COMPLETED